Swiss Dental Startup vVARDIS Begins Trading on NYSE
vVARDIS, a drill-free cavity treatment company, debuted on the New York Stock Exchange under the ticker VVVV on Nov. 13, 2026.
Swiss dental health company vVARDIS made its public market debut on the New York Stock Exchange on Thursday, trading under the ticker symbol VVVV. The listing marks a significant milestone for the startup, which was co-founded by Dr. Haley Abivardi and Dr. Goly Abivardi with the goal of transforming how tooth decay is treated globally.
The company's core offering centers on a drill-free approach to treating cavities — the world's most prevalent non-communicable disease, according to vVARDIS. The founders argue that traditional dental interventions rely heavily on mechanical drilling, and their technology aims to address decay without that invasive step, potentially broadening access and reducing patient anxiety associated with conventional dental procedures.
Read more USDA Forecasts Less Beef, More Chicken Production in 2027 →
The NYSE listing gives vVARDIS access to public capital markets at a moment when investor interest in health technology and preventive care has remained notable. Going public provides the company a platform to scale its drill-free treatment beyond its current footprint and compete in a global oral-health market that affects hundreds of millions of patients annually.
The Abivardi co-founders have positioned vVARDIS as a science-driven consumer dental brand, targeting a gap between over-the-counter oral care products and clinical dental procedures. The IPO signals their intent to accelerate both research investment and commercial expansion following the listing.
Continue reading at All Financial Services & Investing.